Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 5
Out of 5,117 analysts
135
Total ratings
66.32%
Success rate
160.95%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $11.43 | -21.26% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $89.30 | +31.02% | 1 | Dec 1, 2025 | |
| DGX Quest Diagnostics | Maintains: Buy | $200 → $215 | $175.94 | +22.20% | 3 | Oct 21, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $386.06 | -0.27% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $138.39 | +12.00% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $133.79 | -40.20% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $29.30 | +50.17% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,420.10 | -22.54% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $230.32 | +12.89% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $253.89 | +14.22% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $12.28 | +79.15% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $74.50 | +14.09% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $43 → $56 | $45.37 | +22.59% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $33.05 | +5.90% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $96.75 | +29.20% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $16.49 | +45.54% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.77 | +125.99% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $1.98 | +51.52% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $233.74 | -39.25% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $102.98 | -68.93% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $134.95 | -14.78% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $6.48 | +208.64% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $580.74 | +11.93% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $17.70 | -49.15% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.98 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.84 | +552.17% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $6.46 | +828.79% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.73 | +386.26% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $203.66 | +91.50% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.42 | +643.80% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $577.81 | -65.39% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $21.99 | +9.14% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $11.52 | +290.63% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $166.21 | -57.88% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $226.92 | -47.12% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.83 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $48.01 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $10.42 | +427.83% | 1 | Jul 19, 2016 |
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $11.43
Upside: -21.26%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $89.30
Upside: +31.02%
Quest Diagnostics
Oct 21, 2025
Maintains: Buy
Price Target: $200 → $215
Current: $175.94
Upside: +22.20%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $386.06
Upside: -0.27%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $138.39
Upside: +12.00%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $133.79
Upside: -40.20%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $29.30
Upside: +50.17%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,420.10
Upside: -22.54%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $230.32
Upside: +12.89%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $253.89
Upside: +14.22%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $12.28
Upside: +79.15%
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $74.50
Upside: +14.09%
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $45.37
Upside: +22.59%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $33.05
Upside: +5.90%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $96.75
Upside: +29.20%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $16.49
Upside: +45.54%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.77
Upside: +125.99%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $1.98
Upside: +51.52%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $233.74
Upside: -39.25%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $102.98
Upside: -68.93%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $134.95
Upside: -14.78%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $6.48
Upside: +208.64%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $580.74
Upside: +11.93%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $17.70
Upside: -49.15%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.98
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.84
Upside: +552.17%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $6.46
Upside: +828.79%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.73
Upside: +386.26%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $203.66
Upside: +91.50%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.42
Upside: +643.80%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $577.81
Upside: -65.39%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $21.99
Upside: +9.14%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $11.52
Upside: +290.63%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $166.21
Upside: -57.88%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $226.92
Upside: -47.12%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.83
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $48.01
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $10.42
Upside: +427.83%